National Patterns of Hospital Admission Versus Home Recovery Following Mastectomy for Breast Cancer

Authors

Leah S. Kim, Department of Surgery, Yale University School of Medicine, New Haven, CT, USA.
Miranda S. Moore, Yale Center for Health Services and Outcome Research, New Haven, CT, USA.
Eric Schneider, Yale Center for Health Services and Outcome Research, New Haven, CT, USA.
Joseph Canner, Yale Center for Health Services and Outcome Research, New Haven, CT, USA.
Haripriya Ayyala, Department of Surgery, Yale University School of Medicine, New Haven, CT, USA.
Judy Chen, Department of Surgery, Yale University School of Medicine, New Haven, CT, USA.
Pavan Anant, Department of Surgery, Yale University School of Medicine, New Haven, CT, USA.
Elena Graetz, Yale Center for Health Services and Outcome Research, New Haven, CT, USA.
Melanie A. Lynch, Department of Surgery, Yale University School of Medicine, New Haven, CT, USA.
Gregory Zanieski, Department of Surgery, Yale University School of Medicine, New Haven, CT, USA.
Alyssa Gillego, Department of Surgery, Yale University School of Medicine, New Haven, CT, USA.
Monica G. Valero, Department of Surgery, Yale University School of Medicine, New Haven, CT, USA.
Ellie M. Proussaloglou, Department of Surgery, Yale University School of Medicine, New Haven, CT, USA.
Elizabeth R. Berger, Department of Surgery, Yale University School of Medicine, New Haven, CT, USA.
Mehra Golshan, Department of Surgery, Yale University School of Medicine, New Haven, CT, USA.
Rachel A. Greenup, Department of Surgery, Yale University School of Medicine, New Haven, CT, USA.
Tristen S. Park, Department of Surgery, Yale University School of Medicine, New Haven, CT, USA. Tristen.park@yale.edu.

Document Type

Article

Publication Title

Annals of surgical oncology

Abstract

BACKGROUND: We examined national patterns of care and perioperative outcomes for women after mastectomy, comparing home recovery (HR) with hospital admission. PATIENTS AND METHODS: Using Martketscan data (2017-2019), women ≥ 18 years old who underwent mastectomy ± reconstruction were identified and classified as either home recovery (same calendar day discharge) or hospital admission (stays > 1 calendar day). Comorbidities and receipt of chemo/immunotherapy 6 months prior to surgery and post-surgical 30-day complications were measured. Logistic regression calculated the odds of any complication by encounter type, adjusting for age, accompanying lymph node (LN) procedure, reconstruction, neoadjuvant chemo- and/or immunotherapy, and select comorbidities. RESULTS: Of 11,789 mastectomy encounters (N = 11,659 women), 4751 (40%) cases utilized HR while 7038 (60%) had hospital admission. HR patients were older (53.6 years old vs. 51.8 years old) with lower rates of reconstruction (60.2 vs. 74.5%, p < 0.001). Rates of neoadjuvant chemotherapy (19.6 vs. 20.9%, p = 0.099) and immunotherapy (3.6 vs. 3.9%, p = 0.445) were similar between groups. Complication rates were lower among HR patients with fewer postoperative hematomas (0.6 vs. 1.3%, p < 0.001) and decreased wound complications (8.5 vs. 9.8%, p = 0.019). In a multivariable analysis, the odds of any complication were approximately 20% lower for HR patients compared with admission patients (aOR 0.81, 95% CI 0.72-0.91, p < 0.001). Unplanned emergency room visits were similar between groups (6.7 vs. 7.2%, p = 0.374); yet fewer hospital re-admissions (2.5 vs. 3.5%, p = 0.003) occurred in women recovering at home. CONCLUSION: HR is a safe option compared with in-hospital admission for clinically appropriate women after mastectomy as they are less likely to experience postoperative complications, emergency department (ED) visits, or hospitalization.

First Page

9088

Last Page

9099

DOI

10.1245/s10434-024-16107-w

Publication Date

12-1-2024

Identifier

39322830 (pubmed); 10.1245/s10434-024-16107-w (doi); 10.1245/s10434-024-16107-w (pii)

This document is currently not available here.

Share

COinS